Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide-Reference-Cited by-同舟云学术

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide

Published:2012-12 Issue:9 Volume:1 Page:1626-1628
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Malvicini Mariana,Piccioni Flavia,Bayo Juan,Fiore Esteban,Atorrasagasti Catalina,Alaniz Laura,Garcia Mariana,Aquino Jorge B.,Gidekel Manuel,Matar Pablo,Mazzolini Guillermo

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/onci.21651

Reference10 articles.

1. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy;Elkord;Expert Opin Biol Ther,2008

2. Immunosuppressive networks in the tumour environment and their therapeutic relevance;Zou;Nat Rev Cancer,2005

3. Camouflage and sabotage: tumor escape from the immune system;Poschke;Cancer Immunol Immunother,2011

4. Cytokines in cancer pathogenesis and cancer therapy;Dranoff;Nat Rev Cancer,2004

5. Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12;Malvicini;Mol Oncol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells;Frontiers in Immunology;2017-06-30

2. Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: A potential target for ‘two-in-one’ cancer chemoimmunotherapeutics;Cancer Letters;2015-12

3. Classification of current anticancer immunotherapies;Oncotarget;2014-12-18

4. Cyclophosphamide and IL-12-transduced DCs Enhance the Antitumor Activity of Tumor Antigen–stimulated DCs and Reduce Tregs and MDSCs Number;Journal of Immunotherapy;2014-11